Transcription of Saving Lives: Pneumococcal Disease: Integrating …
{{id}} {{{paragraph}}}
This initiative is supported by unrestricted educational grants from Merck & Co., Inc. and Pfizer Inc. NFID policies restrict funders from controlling program 2015page 1 of 2 Pneumococcal disease : Hard to say it; easy to get vaccinatedSaving Lives: IntegratingVaccines forAdults IntoRoutine Care Adult Pneumococcal Vaccination Guide for HCPsTwo types of Pneumococcal vaccine are recommended for use in US adults: a 13-valent Pneumococcal conjugate vaccine (PCV13) and a 23-valent Pneumococcal polysaccharide vaccine (PPSV23). Recommendations for their use vary by age and risk factors. Every adult age 65 years and older should receive both PCV13 and PPSV23.
This initiative is supported by unrestricted educational grants from Merck & Co., Inc. and Pfizer Inc. NFID policies restrict funders from controlling program content.
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}